Skip to content

DMT: all studies

Page 10 of 160: studies 91 to 100 of 1,593, newest first. Back to the DMT overview

Research

N, N-Dimethyltryptamine and harmine formulation shifts metastable topography sequences in the cortex

bioRxiv (Cold Spring Harbor Laboratory) December 9, 2025 Maria Niedernhuber, Dila Suay, Michael J Mueller et al. 1 citation preprint

Abstract Classic serotonergic psychedelics are potent modulators of conscious awareness, yet the principles governing their effects on the temporal dynamics of brain activity remain unclear. Dominant theories propose that psychedelics increase the signal diversity and metastability of neural states, but whether this reflects a simple randomization of activity or a more structured reorganization...

DOI: 10.64898/2025.12.04.692302 (opens in new tab) Ministate Metastability Hallucinating Neocortex +14

Extraction of N, N-dimethyltryptamine (DMT) from Mimosa tenuiflora, syn. Mimosa hostilis (Tepescohuite) using supercritical CO 2 and study of its surface activity

Natural Product Research December 6, 2025 Miguel Gonzalo Arenas-Quevedo, Eduardo Olvera-Santillan, Jesús Gracia‐fadrique

This study presents the extraction and characterisation of bioactive compounds from Mimosa tenuiflora (syn. Mimosa hostilis), known as Tepescohuite, using supercritical CO2. Extractions were performed at 314-328 K and 8-22 MPa for 90 min, with CO2 flow rates of 40-50 mL·min-1. The extracts were analysed by HPLC-MS, NMR, UV-Vis and FTIR spectroscopy. The major compound identified was N,...

DOI: 10.1080/14786419.2025.2596353 (opens in new tab) Surface tension Extraction chemistry Supercritical fluid extraction Response surface methodology +9

A streamlined synthesis of 5-methoxy-N,N-dimethyltryptamine, bufotenin, and bufotenin prodrugs from melatonin

ChemRxiv November 26, 2025 Anton A. Homon, P. V. Vara Prasad, Elham Pourian et al. preprint

The recent resurgence in psychedelic research has increased demand for these molecules for clinical studies. Due to the differences between national regulations and considering the dominance of the American market and its continued prohibition of many such molecules, the commercial availability of many of these compounds remains poor. This has also inhibited research into developing scalable...

DOI: 10.26434/chemrxiv-2025-8c92n (opens in new tab) Prodrug Yield engineering Hydrobromide Demethylation +4

DMT-induced shifts in criticality correlate with self-dissolution.

Journal of Neuroscience November 24, 2025 Mona Irrmischer, Marco Aqil, Lisa Luan et al.

Psychedelics profoundly alter subjective experience and brain dynamics. Brain oscillations express signatures of near-critical dynamics, relevant for healthy function. Alterations in the proximity to criticality have been suggested to underlie the experiential and neurological effects of psychedelics. Here, we investigate the effects of a psychedelic substance (DMT) on the criticality of brain...

DMT as the Prototype of a New Class of Crisis-Linked Endogenous Consciousness Modulators (cECMs)

Zenodo (CERN European Organization for Nuclear Research) November 23, 2025 John Swygert preprint

DescriptionThis preprint proposes a new biological classification for N,N-dimethyltryptamine (DMT): crisis-linked endogenous consciousness modulators (cECMs). Using six mechanistically grounded, falsifiable criteria—endogenous neural biosynthesis, deep evolutionary conservation, ultra-rapid pharmacokinetics, multi-receptor promiscuity, crisis-linked release, and induction of information-rich...

DOI: 10.5281/zenodo.17694547 (opens in new tab) Falsifiability Class philosophy Consciousness Artificial neural network +4

Acute experiences and persisting psychological effects associated with an encapsulated DMT-harmala alkaloid combination: results of a phase 1 study.

Scientific Reports November 20, 2025 Daniel Perkins, Andreas Halman, Anna Urokohara et al.

Acute subjective experiences induced by psychedelics have been identified as important mediators of therapeutic outcomes in many studies. Mystical experiences specifically, have been correlated with a range of therapeutic outcomes including reductions in symptoms of depression, anxiety and addiction. This paper assesses acute subjective experiences induced by an encapsulated DMT-harmala...

DOI: 10.1038/s41598-025-25767-x (opens in new tab) Full text (opens in new tab) Clinical study Harmala Mystical experiences Psychedelics: DMT +20

Pharmacodynamic effects and plasma pharmacokinetics of N, N-dimethyltryptamine after intranasal versus subcutaneous administration in male rats.

Psychopharmacology November 15, 2025 Michael H. Baumann, Grant C. Glatfelter, Sara E Walton et al. 1 citation

There is growing interest in the therapeutic utility of psychedelic compounds that act as serotonin-2 A receptor (5-HT2A) agonists. N,N-dimethyltryptamine (DMT) is a 5-HT2A agonist that produces intense and short-lived psychedelic subjective effects, but the compound requires non-oral routes of administration that bypass gastrointestinal metabolism. Intranasal (IN) delivery of DMT represents...

DOI: 10.1007/s00213-025-06879-8 (opens in new tab) Full text (opens in new tab) N,N-Dimethyltryptamine Flat body posture Hypothermia Mass spectrometry +9

Dimethyltryptamine and harmine, components of ayahuasca, prevented cocaine-induced apoptosis in SH-SY5Y human neuroblastoma cells

Archives of Toxicology November 12, 2025 Gilles Salles, Carolina Aparecida de Faria Almeida, Isabella de Carvalho Alves et al.

Ayahuasca is a psychoactive brew traditionally used in religious rituals by indigenous Amazonian populations and South American syncretic religions such as Santo Daime and União do Vegetal. Its psychoactive effects are primarily due to N,N-dimethyltryptamine (DMT), while harmine (HRE), a β-carboline alkaloid, inhibits monoamine oxidase (MAO), enabling DMT's oral bioavailability. Recent studies...

DOI: 10.1007/s00204-025-04208-8 (opens in new tab) Ayahuasca Harmine Apoptosis Flow cytometry +13

Mapping the phenomenology of intranasal 5-MeO-DMT in psychedelic-naïve healthy adults.

Scientific Reports November 6, 2025 Anna O. Ermakova, Fiona Dunbar, Mathieu Seynaeve et al. 3 citations

5-Methoxy-N,N-dimethyltryptamine (5-MeO-DMT) is a naturally occurring psychedelic tryptamine. Plants containing 5-MeO-DMT have been used throughout history, and in recent years both synthetic and toad-derived 5-MeO-DMT use is being increasingly reported in naturalistic settings as well as clinical research. However, its subjective effects are not well characterised, and no qualitative research...